松本油脂製薬 disclosed after the market close on 13 November that consolidated ordinary income for the first half was ¥5.12 billion, up 16.1% year on year, with progress against the full-year plan at 52.8%. It also forecast second-half ordinary income at ¥4.57 billion, down 28.5% year on year.
松本油脂製薬's consolidated ordinary income for the cumulative second quarter of the fiscal year ending March 2027 (April-September) was ¥5.12 billion, up 16.1% year on year, bringing progress against the full-year plan to 52.8%.
The latest outlook estimates consolidated ordinary income for the second half (October-March) at ¥4.57 billion, down 28.5% year on year.
Consolidated ordinary income for the July-September quarter was ¥2.22 billion, up 0.6% year on year, while the operating margin on sales improved from 16.8% to 17.7%.